• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2011 年,瑞典分离到一株淋病奈瑟菌临床分离株,该分离株具有脑膜炎奈瑟菌 porA 基因且缺乏脯氨酰基内肽酶活性:基因和培养诊断结果可能出现假阴性的危险。

Clinical Neisseria gonorrhoeae isolate with a N. meningitidis porA gene and no prolyliminopeptidase activity, Sweden, 2011: danger of false-negative genetic and culture diagnostic results.

机构信息

WHO Collaborating Centre for Gonorrhoea and other STIs, Swedish Reference Laboratory for Pathogenic Neisseria, Department of Laboratory Medicine, Microbiology, Orebro University Hospital, Orebro, Sweden.

出版信息

Euro Surveill. 2012 Mar 1;17(9):20102.

PMID:22401563
Abstract

We describe a Neisseria gonorrhoeae strain, found in Sweden in 2011, that harbours a N. meningitidis porA gene causing false-negative results in PCRs targeting the gonococcal porA pseudogene. Furthermore, the strain had no prolyliminopeptidase (PIP) activity that many commercial biochemical kits for species verification in culture rely on. Enhanced awareness of the spread of such strains and screening for them can be crucial.

摘要

我们描述了一株淋病奈瑟菌菌株,该菌株于 2011 年在瑞典发现,其携带脑膜炎奈瑟菌 porA 基因,导致针对淋球菌 porA 假基因的 PCR 检测出现假阴性结果。此外,该菌株缺乏许多商业化的基于培养物的种属鉴定用生化试剂盒所依赖的脯氨酰肽酶(PIP)活性。提高对这类菌株传播的认识并对其进行筛查可能至关重要。

相似文献

1
Clinical Neisseria gonorrhoeae isolate with a N. meningitidis porA gene and no prolyliminopeptidase activity, Sweden, 2011: danger of false-negative genetic and culture diagnostic results.2011 年,瑞典分离到一株淋病奈瑟菌临床分离株,该分离株具有脑膜炎奈瑟菌 porA 基因且缺乏脯氨酰基内肽酶活性:基因和培养诊断结果可能出现假阴性的危险。
Euro Surveill. 2012 Mar 1;17(9):20102.
2
Most but not all laboratories can detect the recently emerged Neisseria gonorrhoeae porA mutants - results from the QCMD 2013 N. gonorrhoeae external quality assessment programme.大多数(但非全部)实验室能够检测到最近出现的淋病奈瑟菌 porA 突变体 - 来自 2013 年 QCMD 淋病奈瑟菌外部质量评估计划的结果。
Euro Surveill. 2014 Feb 27;19(8):20711. doi: 10.2807/1560-7917.es2014.19.8.20711.
3
False-negative results using Neisseria gonorrhoeae porA pseudogene PCR - a clinical gonococcal isolate with an N. meningitidis porA sequence, Australia, March 2011.采用淋病奈瑟菌 porA 假基因 PCR 检测出现假阴性结果-2011 年 3 月澳大利亚一株具有脑膜炎奈瑟菌 porA 序列的临床淋病分离株。
Euro Surveill. 2011 May 26;16(21):19874.
4
Prevalence, phenotypic and genetic characteristics of prolyliminopeptidase-negative Neisseria gonorrhoeae isolates in Sweden during 2000-2007.2000-2007 年期间瑞典淋病奈瑟菌分离株中脯氨酰肽酶阴性的流行率、表型和遗传特征。
APMIS. 2009 Dec;117(12):900-4. doi: 10.1111/j.1600-0463.2009.02552.x.
5
Evolution of Neisseria gonorrhoeae is a continuing challenge for molecular detection of gonorrhoea: false negative gonococcal porA mutants are spreading internationally.淋球菌的进化对淋病分子检测构成持续挑战:国际上正在传播假阴性淋球菌 porA 突变体。
Sex Transm Infect. 2013 May;89(3):197-201. doi: 10.1136/sextrans-2012-050829. Epub 2012 Dec 13.
6
Evidence that the gonococcal porA pseudogene is present in a broad range of Neisseria gonorrhoeae strains; suitability as a diagnostic target.淋球菌porA假基因存在于广泛的淋病奈瑟菌菌株中的证据;作为诊断靶点的适用性。
Pathology. 2006 Oct;38(5):445-8. doi: 10.1080/00313020600928253.
7
Clinical validation of a real-time polymerase chain reaction detection of Neisseria gonorrheae porA pseudogene versus culture techniques.淋病奈瑟菌porA假基因实时聚合酶链反应检测与培养技术的临床验证
Sex Transm Dis. 2008 May;35(5):517-20. doi: 10.1097/OLQ.0b013e3181644bc9.
8
Prevalence of porA pseudogene deletion among Neisseria gonorrhoeae isolates referred to the UK's Gonococcal Resistance to Antimicrobials Surveillance Program.提交至英国淋病奈瑟菌抗菌药物耐药性监测计划的淋病奈瑟菌分离株中porA假基因缺失的流行情况。
Sex Health. 2017 Aug;14(4):392-393. doi: 10.1071/SH16162.
9
A duplex Neisseria gonorrhoeae real-time polymerase chain reaction assay targeting the gonococcal porA pseudogene and multicopy opa genes.一种针对淋病奈瑟菌porA假基因和多拷贝opa基因的双重淋病奈瑟菌实时聚合酶链反应检测方法。
Diagn Microbiol Infect Dis. 2008 May;61(1):6-12. doi: 10.1016/j.diagmicrobio.2007.12.007. Epub 2008 Jan 14.
10
A fast real-time polymerase chain reaction method for sensitive and specific detection of the Neisseria gonorrhoeae porA pseudogene.一种用于灵敏且特异检测淋病奈瑟菌porA假基因的快速实时聚合酶链反应方法。
J Mol Diagn. 2006 Nov;8(5):574-81. doi: 10.2353/jmoldx.2006.060024.

引用本文的文献

1
Neisseria gonorrhoeae diagnostic escape from a gyrA-based test for ciprofloxacin susceptibility and the effect on zoliflodacin resistance: a bacterial genetics and experimental evolution study.淋病奈瑟菌基于 gyrA 的环丙沙星药敏检测诊断逃逸及其对唑林达星耐药性的影响:细菌遗传学和实验进化研究。
Lancet Microbe. 2023 Apr;4(4):e247-e254. doi: 10.1016/S2666-5247(22)00356-1. Epub 2023 Feb 28.
2
Targeted surveillance strategies for efficient detection of novel antibiotic resistance variants.靶向监测策略可有效检测新型抗生素耐药变体。
Elife. 2020 Jun 30;9:e56367. doi: 10.7554/eLife.56367.
3
The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization.
2016年世界卫生组织淋病奈瑟菌新型参考菌株用于实验室检测的全球质量保证:表型、基因及参考基因组特征分析
J Antimicrob Chemother. 2016 Nov;71(11):3096-3108. doi: 10.1093/jac/dkw288. Epub 2016 Jul 17.
4
Multiplex Real-Time PCR Assay with High-Resolution Melting Analysis for Characterization of Antimicrobial Resistance in Neisseria gonorrhoeae.用于淋病奈瑟菌耐药性特征分析的多重实时聚合酶链反应及高分辨率熔解分析检测法
J Clin Microbiol. 2016 Aug;54(8):2074-81. doi: 10.1128/JCM.03354-15. Epub 2016 May 25.
5
Evaluation of the New BD Max GC Real-Time PCR Assay, Analytically and Clinically as a Supplementary Test for the BD ProbeTec GC Qx Amplified DNA Assay, for Molecular Detection of Neisseria gonorrhoeae.新型BD Max GC实时荧光定量PCR检测方法作为BD ProbeTec GC Qx扩增DNA检测方法的补充检测方法用于淋病奈瑟菌分子检测的分析及临床评估
J Clin Microbiol. 2015 Dec;53(12):3935-7. doi: 10.1128/JCM.01962-15. Epub 2015 Oct 14.
6
Purification of DNA eluates from the ProbeTec GC Q(x) assay on BD Viper™ XTR allows for further analysis and confirmation of gonorrhea.从 BD Viper™ XTR 上的 ProbeTec GC Q(x) 检测中纯化 DNA 洗脱液可进一步分析和确认淋病。
Eur J Clin Microbiol Infect Dis. 2014 Jan;33(1):49-54. doi: 10.1007/s10096-013-1927-4. Epub 2013 Aug 1.
7
Analytical evaluation of GeneXpert CT/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis.GeneXpert CT/NG 分析评估,首个用于同时检测淋病奈瑟菌和沙眼衣原体的即时检测基因检测点。
J Clin Microbiol. 2013 Jun;51(6):1945-7. doi: 10.1128/JCM.00806-13. Epub 2013 Apr 3.